Lucence INSIGHT™ is a multi-cancer screening tool that screens for the risk of multiple cancers in one simple blood draw.

Lucence INSIGHT™ is based on a proprietary amplicon-based technology to screen for the risks of cancer with a sensitivity of and a specificity of 99.2%. The test detects cancer-associated alterations circulating in blood. Advanced sequence analysis predicts the site of origin. The report will present your result as Areas of Concern, with an accuracy of 90%.

# LucenceINSIGHT™ is recommended for use in conjunction with existing screening tools for individuals without a personal history of cancer.

Reference : https://www.cancer.gov.hk/tc/hong_kong_cancer/overview_of_cancer_statistics_in_hong_kong.html
Reference : 1. American Cancer Society. https://www.cancer.org/cancer.html ; 2. National Cancer Institute. https://seer.cancer.gov ; 3. Data on file.

Lucence INSIGHT™
ctDNA Cancer Risk Assessment